ID   ClearCa-8
AC   CVCL_X577
SY   clearCa-8
DR   Wikidata; Q54813628
RX   CelloPub=CLPUB00407;
RX   PubMed=9146668;
RX   PubMed=11139287;
CC   Doubling time: 112 hours (PubMed=9146668).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 7
//
RX   CelloPub=CLPUB00407;
RA   Krieg A.;
RT   "Characterization and functional analysis of the TRAIL system and
RT   the inhibitor of apoptosis protein (IAP) family in human neoplasia.";
RL   Thesis MD (2005); Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany.
//
RX   PubMed=9146668; DOI=10.1016/S0022-5347(01)64778-5;
RA   Ramp U., Jaquet K., Reinecke P., Schardt C., Friebe-Hoffmann U.,
RA   Nitsch T., Marx N., Gabbert H.E., Gerharz C.-D.;
RT   "Functional intactness of stimulatory and inhibitory autocrine loops
RT   in human renal carcinoma cell lines of the clear cell type.";
RL   J. Urol. 157:2345-2350(1997).
//
RX   PubMed=11139287; DOI=10.1038/sj.cdd.4400746;
RA   Dejosez M., Ramp U., Mahotka C., Krieg A., Walczak H., Gabbert H.E.,
RA   Gerharz C.-D.;
RT   "Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell
RT   carcinomas and its enhancement by topotecan.";
RL   Cell Death Differ. 7:1127-1136(2000).
//